Some thoughts about recent hypertension trials.
作者信息
Conti C Richard
出版信息
Clin Cardiol. 2007 Jun;30(6):268-70. doi: 10.1002/clc.20152.
Abstract
摘要
相似文献
1
Some thoughts about recent hypertension trials.
Clin Cardiol. 2007 Jun;30(6):268-70. doi: 10.1002/clc.20152.
2
Are guidelines effectively guiding antihypertensive therapy?
Am J Cardiol. 2007 Jul 1;100(1):143-4. doi: 10.1016/j.amjcard.2007.02.070. Epub 2007 May 21.
3
Role of home blood pressure and ambulatory blood pressure monitoring in decisions of when and whom to treat: recommendations for practicing clinicians.
J Cardiometab Syndr. 2006 Summer;1(3):222-4. doi: 10.1111/j.1559-4564.2006.05528.x.
4
Current role of beta-blockers in the treatment of hypertension.
Expert Opin Pharmacother. 2010 Nov;11(16):2599-607. doi: 10.1517/14656566.2010.482561. Epub 2010 Apr 28.
5
Jnc 7.5.
J Clin Hypertens (Greenwich). 2007 Nov;9(11):901-4. doi: 10.1111/j.1524-6175.2007.06303.x.
6
[Updates of European recommendations on arterial hypertension].
Kardiologiia. 2010;50(10):80-5.
7
Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
J Cardiometab Syndr. 2006 Spring;1(2):146-8. doi: 10.1111/j.1559-4564.2006.05527.x.
8
Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease.
J Am Pharm Assoc (2003). 2007 Sep-Oct;47(5):662-3. doi: 10.1331/JAPhA.2007.07525.
9
PREFACE: "The Lower the Better" Association between White-coat Effect-excluded Blood Pressure and Cardiovascular Events in High-risk Hypertension: Insights from SPRINT.
Curr Hypertens Rev. 2016;12(1):2-10. doi: 10.2174/157340211201160304173629.
10
Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention.
Hypertension. 2017 Mar;69(3):e2-e9. doi: 10.1161/HYPERTENSIONAHA.116.08249. Epub 2017 Jan 23.
本文引用的文献
1
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
Am J Cardiol. 2006 Oct 1;98(7):890-4. doi: 10.1016/j.amjcard.2006.04.030. Epub 2006 Aug 7.
2
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Ann Intern Med. 2006 Jun 20;144(12):884-93. doi: 10.7326/0003-4819-144-12-200606200-00005.
3
Predictors of adverse outcome among patients with hypertension and coronary artery disease.
J Am Coll Cardiol. 2006 Feb 7;47(3):547-51. doi: 10.1016/j.jacc.2005.09.031. Epub 2006 Jan 18.
4
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
Lancet. 2005;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3.
5
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet. 2005;366(9489):895-906. doi: 10.1016/S0140-6736(05)67185-1.
6
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
JAMA. 2004 Nov 10;292(18):2217-25. doi: 10.1001/jama.292.18.2217.
7
Adverse prognostic significance of new diabetes in treated hypertensive subjects.
Hypertension. 2004 May;43(5):963-9. doi: 10.1161/01.HYP.0000125726.92964.ab. Epub 2004 Mar 22.
Zotero 插件